ADME-toxicology testing is the evaluation of the metabolism of a drug molecule and its toxicity in an organism. ADME describes the pharmacological changes of a drug inside a living organism. These studies are traditionally carried out in vivo or in vitro in a controlled laboratory environment.
The key factors assisting the growth of instruments and assay systems market are enhanced accuracy and predictability of ADME –Tox technology, market shift towards in-vitro assays for toxicological studies and increasing global adoption of novel ADME toxicology testing instruments and assay systems.

Market Analysis and Insights: Global ADME-Toxicology Testing Market
The global ADME-Toxicology Testing market size is projected to reach US$ 8340.9 million by 2027, from US$ 4464.2 million in 2020, at a CAGR of 9.2% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global ADME-Toxicology Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global ADME-Toxicology Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global ADME-Toxicology Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global ADME-Toxicology Testing market.

Global ADME-Toxicology Testing Scope and Market Size
ADME-Toxicology Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global ADME-Toxicology Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
In-vitro Testing
Biochemical Testing
Cell Testing
In-vivo Testing

Segment by Application
Laboratories
Pharmaceutical
Medical
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Accelrys (Dassault Systemes)
Agilent Technologies
Bio-Rad Laboratories
Promega
Sigma Aldrich
Thermo Fisher Scientific
Cyprtorex
CytoPulse
Entelos
LI-COR Biosciences
Mattek
Miltenyi Biotec
Molecular Toxicology
Quintiles
RTI Health Solutions
SBW
Xenobiotic Detection Systems
Xenometrix